Research


I. Biomarker screening using glycan/lectin microarray

  1. Glycan structure analysis
  2. Glycan/Lectin microarray platform development
  3. Immune cell/Cancer cell/Aging cell-specific lectin and glycan screening

3_사본(1).png

II. Immunotherapy platform through tumor environment-specific glycan-targeted immune activity control

  1. Enhanced immune activity based on effector T cell-specific glycan targeting ligand delivery
  2. Disabling the immune evasion of cancer based on tumor-specific glycan synthase gene knockout

BRL.png

III. Cancer-targeting drug delivery

  1. Protein nanocage-based drug delivery carrier development
  2. Triple-layered capsule-based drug delivery carrier with reversible antibody binding and stimuli-responsive properties
  3. Micell-based drug delivery carrier
  4. Cancer-specific glycan-targeted chemoimmunotherapy
그림_3.jpg

IV. Disease diagnosis

  1. Glycan-based diagnostic platform development
  2. Lectin-based diagnostic platform development
  3. Antibody-based diagnostic platform development
  4. Cancer diagnosis
  5. Virus/Pathogen detection
Figure_1.jpg

More details will be updated soon.